Terumo Corporation (FRA:TUO)

Market Cap	19.33B
Revenue (ttm)	6.12B
Net Income (ttm)	752.56M
Shares Out	n/a
EPS (ttm)	0.51
PE Ratio	25.68
Forward PE	n/a
Dividend	0.17 (1.25%)
Ex-Dividend Date	Sep 29, 2025

Volume	n/a
Average Volume	220
Open	13.00
Previous Close	13.10
Day's Range	13.00 - 13.00
52-Week Range	12.90 - 19.60
Beta	n/a
RSI	44.15
Earnings Date	Feb 10, 2026

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems,...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1921
• Employees: 30,591
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TUO

Financial Performance

In 2024, Terumo's revenue was 1.04 trillion, an increase of 12.40% compared to the previous year's 921.86 billion. Earnings were 116.98 billion, an increase of 9.97%.

Financial numbers in JPY